Publications

Detailed Information

CD4(+)FoxP3(+) T regulatory cells in drug-susceptible and multidrug-resistant tuberculosis

DC Field Value Language
dc.contributor.authorLim, Hyo-Jeong-
dc.contributor.authorPark, Jong Sun-
dc.contributor.authorCho, Young-Jae-
dc.contributor.authorYoon, Ho Il-
dc.contributor.authorPark, Kyoung Un-
dc.contributor.authorLee, Choon-Tack-
dc.contributor.authorLee, Jae Ho-
dc.date.accessioned2025-02-20T07:56:02Z-
dc.date.available2025-02-20T07:56:02Z-
dc.date.created2021-05-03-
dc.date.created2021-05-03-
dc.date.issued2013-09-
dc.identifier.citationTuberculosis, Vol.93 No.5, pp.523-528-
dc.identifier.issn1472-9792-
dc.identifier.urihttps://hdl.handle.net/10371/217089-
dc.description.abstractRegulatory T cells (T-reg) increase in active tuberculosis (TB). However, whether T-reg-mediated immune suppression affect the susceptibility to active TB or development of multidrug-resistant (MDR) TB is not yet clear. We compared circulatory T-reg frequencies in drug susceptible (DS) and MDR TB before and after anti-TB treatment. Circulatory T-reg frequencies were measured in blood samples from 33 DS TB, 7 mycobacterial culture-positive active MDR TB, 16 stable MDR TB who had been culture negative for at least 6 months, and 14 healthy controls before and after treatment. T-reg frequency was measured by flow cytometry using cell-surface marker CD4 and intracellular marker FoxP3. T-reg frequency was higher in DS TB and active MDR TB patients than in healthy controls (p < 0.05), with no significant difference between the former. T-reg frequency was higher in patients with sputum acid-fast bacilli smear-positive TB than in patients with smear-negative TB, but the increase did not correlate with the radiologic extent of TB or presence of a cavity. After successful treatment, T-reg decreased to control levels in DS TB and MDR TB patents. The pattern of change, in which T-reg frequency increased during active infection and normalized to control levels after successful treatment, was similar in DS and MDR TB patients. (c) 2013 Elsevier Ltd. All rights reserved.-
dc.language영어-
dc.publisherChurchill Livingstone-
dc.titleCD4(+)FoxP3(+) T regulatory cells in drug-susceptible and multidrug-resistant tuberculosis-
dc.typeArticle-
dc.identifier.doi10.1016/j.tube.2013.06.001-
dc.citation.journaltitleTuberculosis-
dc.identifier.wosid000323546200007-
dc.identifier.scopusid2-s2.0-84882266402-
dc.citation.endpage528-
dc.citation.number5-
dc.citation.startpage523-
dc.citation.volume93-
dc.description.isOpenAccessN-
dc.contributor.affiliatedAuthorPark, Jong Sun-
dc.contributor.affiliatedAuthorYoon, Ho Il-
dc.contributor.affiliatedAuthorPark, Kyoung Un-
dc.contributor.affiliatedAuthorLee, Choon-Tack-
dc.contributor.affiliatedAuthorLee, Jae Ho-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.subject.keywordPlusIMMUNE-RESPONSES-
dc.subject.keywordPlusPATTERNS-
dc.subject.keywordPlusBLOOD-
dc.subject.keywordPlusFOXP3-
dc.subject.keywordAuthorDisease susceptibility-
dc.subject.keywordAuthorRegulatory T-cells-
dc.subject.keywordAuthorFoxP3 protein-
dc.subject.keywordAuthorMultidrug-resistant tuberculosis-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Related Researcher

  • College of Medicine
  • Department of Medicine
Research Area Interstitial lung disease, Pneumonia, Pulmonary fibrosis, 간질성 폐질환, 폐렴, 폐섬유증

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share